Research has optimized the process of making human brain 'organoids' -- miniature 3D organ models -- so they consistently follow growth patterns observed in the developing human brain. Researchers can use this reproducible experimental system to test drugs for neuropsychiatric diseases like autism spectrum disorder and schizophrenia directly in human tissues.